Billy W Loo

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer
    David Benjamin Shultz
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA Electronic address
    Semin Radiat Oncol 25:78-86. 2015
  2. ncbi request reprint Indirect MR lymphangiography of the head and neck using conventional gadolinium contrast: a pilot study in humans
    Billy W Loo
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305 5847, USA, and Department of General Surgery, Singapore General Hospital, Singapore
    Int J Radiat Oncol Biol Phys 66:462-8. 2006
  3. doi request reprint Motion management and image guidance for thoracic tumor radiotherapy: clinical treatment programs
    Billy W Loo
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, Calif, USA
    Front Radiat Ther Oncol 43:271-91. 2011
  4. doi request reprint Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy
    Jonathan A Abelson
    Department of Radiation Oncology, School of Medicine, Stanford University, Stanford, CA 94305, USA
    Lung Cancer 78:219-24. 2012
  5. doi request reprint Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy
    Julian C Hong
    Department of Radiation Oncology, Stanford University, CA, USA
    J Appl Clin Med Phys 14:4046. 2013
  6. pmc Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer
    James D Murphy
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 80:514-21. 2011
  7. doi request reprint Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer
    Millie Das
    Department of Medicine, Division of Oncology, Stanford University, CA, USA
    Clin Lung Cancer 12:280-5. 2011
  8. ncbi request reprint Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer
    Margaret M Kozak
    Department of Radiation Oncology, Stanford University, Stanford, California 94305 5847, USA
    J Thorac Oncol 6:920-6. 2011
  9. pmc Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer
    Percy Lee
    Department of Radiation Oncology, Stanford University, CA, USA
    Clin Lung Cancer 13:52-8. 2012
  10. pmc 4D CT lung ventilation images are affected by the 4D CT sorting method
    Tokihiro Yamamoto
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847 and Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California 95817
    Med Phys 40:101907. 2013

Detail Information

Publications72

  1. doi request reprint To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer
    David Benjamin Shultz
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA Electronic address
    Semin Radiat Oncol 25:78-86. 2015
    ..Thus, appropriate patient selection is a vital, evolving, and controversial topic. ..
  2. ncbi request reprint Indirect MR lymphangiography of the head and neck using conventional gadolinium contrast: a pilot study in humans
    Billy W Loo
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305 5847, USA, and Department of General Surgery, Singapore General Hospital, Singapore
    Int J Radiat Oncol Biol Phys 66:462-8. 2006
    ....
  3. doi request reprint Motion management and image guidance for thoracic tumor radiotherapy: clinical treatment programs
    Billy W Loo
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, Calif, USA
    Front Radiat Ther Oncol 43:271-91. 2011
    ..This discussion will present practical solutions for motion management and image guidance of radiotherapy for thoracic tumors, and most of these concepts are widely applicable to treatment of other tumor sites as well...
  4. doi request reprint Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy
    Jonathan A Abelson
    Department of Radiation Oncology, School of Medicine, Stanford University, Stanford, CA 94305, USA
    Lung Cancer 78:219-24. 2012
    ....
  5. doi request reprint Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy
    Julian C Hong
    Department of Radiation Oncology, Stanford University, CA, USA
    J Appl Clin Med Phys 14:4046. 2013
    ..Marker migration between implantation and simulation is limited and unlikely to cause geometric miss during tracking...
  6. pmc Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer
    James D Murphy
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 80:514-21. 2011
    ..To explore the prognostic value of metabolic tumor volume measured on postradiation (18)F-fluorodeoxyglucose positron emission tomography (PET) imaging in patients with head-and-neck cancer...
  7. doi request reprint Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer
    Millie Das
    Department of Medicine, Division of Oncology, Stanford University, CA, USA
    Clin Lung Cancer 12:280-5. 2011
    ..We hypothesized that using a trimodality approach in selected patients with stage IIIA/IIIB disease would be both feasible and efficacious with reasonable toxicity...
  8. ncbi request reprint Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer
    Margaret M Kozak
    Department of Radiation Oncology, Stanford University, Stanford, California 94305 5847, USA
    J Thorac Oncol 6:920-6. 2011
    ....
  9. pmc Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer
    Percy Lee
    Department of Radiation Oncology, Stanford University, CA, USA
    Clin Lung Cancer 13:52-8. 2012
    ..We evaluated the prognostic value of metabolic tumor volume (MTV), a measure of tumor burden on FDG-PET imaging, in patients with non-small-cell lung cancer (NSCLC) treated definitively...
  10. pmc 4D CT lung ventilation images are affected by the 4D CT sorting method
    Tokihiro Yamamoto
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847 and Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California 95817
    Med Phys 40:101907. 2013
    ..The purpose of this study was to quantify the variability of 4D CT ventilation imaging due to 4D CT sorting...
  11. doi request reprint Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control
    Megan E Daly
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 80:1412-22. 2011
    ..Few studies have evaluated the use of intensity-modulated radiotherapy (IMRT) for squamous cell carcinoma (SCC) of the oral cavity (OC). We report clinical outcomes and failure patterns for these patients...
  12. doi request reprint Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors
    Nicholas Trakul
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    J Thorac Oncol 7:1462-5. 2012
    ..Here we report our experience with SABR for lung tumors in previously irradiated regions...
  13. doi request reprint Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors
    Nicholas Trakul
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
    Int J Radiat Oncol Biol Phys 84:231-7. 2012
    ..Current stereotactic ablative radiotherapy (SABR) protocols for lung tumors prescribe a uniform dose regimen irrespective of tumor size. We report the outcomes of a lung tumor volume-adapted SABR dosing strategy...
  14. doi request reprint Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx
    Megan E Daly
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, California, USA
    Head Neck 33:103-11. 2011
    ..Limited data evaluate intensity-modulated radiotherapy (IMRT) for cancers of the hypopharynx and larynx. We report clinical outcomes and failure patterns for these patients...
  15. doi request reprint Radiotherapy for nonadenoid cystic carcinomas of major salivary glands
    Melody P Chung
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    Am J Otolaryngol 34:425-30. 2013
    ..To report outcomes in patients treated with postoperative radiotherapy for nonadenoid cystic carcinomas of the major salivary glands...
  16. pmc Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy
    Ruijiang Li
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 87:917-23. 2013
    ..To develop and clinically evaluate a volumetric imaging technique for assessing intrafraction geometric and dosimetric accuracy of stereotactic ablative radiation therapy (SABR)...
  17. doi request reprint A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer
    Jeremy P Harris
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 88:872-84. 2014
    ..We therefore performed a population-based comparative effectiveness analysis of IMRT, conventional 3-dimensional conformal radiation therapy (3D-CRT), and 2-dimensional radiation therapy (2D-RT) in stage III NSCLC...
  18. doi request reprint Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure
    Megan E Daly
    Department of Radiation Oncology, Stanford University, Stanford, California 94305, USA
    Int J Radiat Oncol Biol Phys 76:1339-46. 2010
    ..To report outcomes, failures, and toxicities in patients treated with intensity-modulated radiotherapy (IMRT) for squamous cell carcinoma of the oropharynx...
  19. doi request reprint Reproducibility of four-dimensional computed tomography-based lung ventilation imaging
    Tokihiro Yamamoto
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, Stanford, CA 94305 5847, USA
    Acad Radiol 19:1554-65. 2012
    ..Understanding its reproducibility is a prerequisite for clinical applications. The purpose of this study was to quantify the reproducibility of 4D CT ventilation imaging over different days and the same session...
  20. pmc Validation that metabolic tumor volume predicts outcome in head-and-neck cancer
    Chad Tang
    Department of Radiation Oncology, Stanford University, Stanford, CA, USA
    Int J Radiat Oncol Biol Phys 83:1514-20. 2012
    ....
  21. ncbi request reprint Four-dimensional computed tomography pulmonary ventilation images vary with deformable image registration algorithms and metrics
    Tokihiro Yamamoto
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Med Phys 38:1348-58. 2011
    ..The purpose of this study was to quantify the variability of the 4D-CT ventilation to DIR algorithms and metrics...
  22. doi request reprint High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors
    Julian C Hong
    Department of Radiation Oncology, Stanford University, Stanford, California 94305 5847, USA
    Int J Radiat Oncol Biol Phys 81:85-90. 2011
    ....
  23. pmc Intrafraction verification of gated RapidArc by using beam-level kilovoltage X-ray images
    Ruijiang Li
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 83:e709-15. 2012
    ..To verify the geometric accuracy of gated RapidArc treatment using kV images acquired during dose delivery...
  24. doi request reprint Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal
    Jose G Bazan
    Department of Radiation Oncology, Stanford University, Stanford, California 94305 5847, USA
    J Nucl Med 54:27-32. 2013
    ..PET imaging has become a useful diagnostic tool in patients with anal cancer. We evaluated the prognostic value of metabolic tumor volume (MTV) in patients with anal cancer treated with definitive chemoradiotherapy...
  25. pmc Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia
    David J Carlson
    Stanford University School of Medicine, Department of Radiation Oncology, Stanford, CA, USA
    Int J Radiat Oncol Biol Phys 79:1188-95. 2011
    ..The purpose of this study is to quantify the effect of different radiation fractionation schemes on tumor cell killing, assuming a realistic distribution of tumor oxygenation...
  26. pmc Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
    Michael S Binkley
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA
    Radiat Oncol 11:40. 2016
    ..Having previously observed a dose-volume response for localized lobar volume reduction after stereotactic ablative radiotherapy (SABR) for lung tumors, we investigated the time course and factors associated with volume reduction...
  27. doi request reprint Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
    Aadel A Chaudhuri
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Lung Cancer 89:50-6. 2015
    ..Here we report our institution's experience in treating central and ultra-central lung tumor patients with SABR...
  28. doi request reprint Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images
    Tokihiro Yamamoto
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California Electronic address
    Int J Radiat Oncol Biol Phys 90:414-22. 2014
    ....
  29. doi request reprint Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer
    David B Shultz
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
    Clin Lung Cancer 15:294-301.e3. 2014
    ..The aim of this study was to identify imaging-based predictors of progression in patients treated with SABR for stage I NSCLC...
  30. doi request reprint Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors
    Michael B Liu
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Pract Radiat Oncol 3:294-300. 2013
    ..To determine the clinical impact of calculated dose differences between effective path length (EPL) and Monte Carlo (MC) algorithms in stereotactic ablative radiation therapy (SABR) of lung tumors...
  31. doi request reprint Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer
    Priya Jayachandran
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 84:471-7. 2012
    ..To correlate the prechemoradiotherapy (CRT) and post-CRT metabolic tumor volume (MTV) on positron emission tomography (PET) scanning with the pathologic response and survival in patients receiving preoperative CRT for esophageal cancer...
  32. ncbi request reprint Reducing 4D CT artifacts using optimized sorting based on anatomic similarity
    Eric Johnston
    Department of Physics, Stanford University, Stanford, California 94305, USA
    Med Phys 38:2424-9. 2011
    ..The purpose of this work is to demonstrate a method of reducing motion artifacts in 4D CT by incorporating anatomic similarity into phase or displacement based sorting protocols...
  33. pmc Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer
    Trang H La
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 74:1335-41. 2009
    ....
  34. pmc Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease
    Diane Tseng
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, Stanford, CA 94305, USA
    Radiat Oncol 7:5. 2012
    ..We hypothesized that quantitative PET parameters may have predictive value beyond that of traditional clinical factors such as the International Prognostic Score (IPS) among Hodgkin's disease (HD) patients...
  35. doi request reprint On-board imaging validation of optically guided stereotactic radiosurgery positioning system for conventionally fractionated radiotherapy for paranasal sinus and skull base cancer
    Peter G Maxim
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 81:1153-9. 2011
    ..To evaluate the positioning accuracy of an optical positioning system for stereotactic radiosurgery in a pilot experience of optically guided, conventionally fractionated, radiotherapy for paranasal sinus and skull base tumors...
  36. doi request reprint Anatomic optimization of lung tumor stereotactic ablative radiation therapy
    Amy S Yu
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Pract Radiat Oncol 5:e607-13. 2015
    ....
  37. doi request reprint Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
    Michael S Binkley
    Department of Radiation Oncology and Cancer Institute, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 92:1044-52. 2015
    ..Stereotactic ablative radiation therapy (SABR) is increasingly used to treat lung oligometastases. We set out to determine the safety and efficacy of this approach and to identify factors associated with outcomes...
  38. pmc Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy
    Erqi L Pollom
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 92:568-76. 2015
    ....
  39. pmc Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer
    Anders Carlsson
    The Scripps Research Institute, Department of Cell Biology, La Jolla, CA Department of Medicine, Stanford University School of Medicine Stanford, CA Centre Hospitalier de l Universite de Sherbrooke, Department of Nuclear Medicine and Radiobiology, Sherbrooke, Québec The California Pacific Medical Center Research Institute, San Francisco, CA The VA Palo Alto Health Care System, Section of Nuclear Medicine, Palo Alto, CA Department of Radiology, Stanford University School of Medicine, Stanford, CA The VA Palo Alto Health Care System Section of Pulmonary and Critical Care, Palo Alto, CA Department of Radiation Oncology Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA The VA Palo Alto Health Care System Section of Cardiothoracic Surgery, Palo Alto, CA Scripps Clinic, Department of Pathology, La Jolla, CA Nuclear Medicine Division, University of San Diego Medical Center, San Diego, CA The Moores Cancer Center, University of San Diego Medical Center, La Jolla, CA The Billings Clinic, Department of Hematology Oncology, Billings, MT Departments of Bioengineering and Materials Science and Engineering, Stanford University School of Medicine, Stanford, CA
    J Thorac Oncol 9:1111-9. 2014
    ..We examined CTM test performance using a sensitive detection platform to identify stage I non-small-cell lung cancer (NSCLC) patients undergoing imaging evaluation...
  40. pmc Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity
    James D Murphy
    Department of Radiation Oncology, Stanford University School of Medicine, United States
    Radiother Oncol 101:356-61. 2011
    ..To explore the relationship between pathologic tumor volume and volume estimated from different tumor segmentation techniques on (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in oral cavity cancer...
  41. ncbi request reprint Quantification of motion of different thoracic locations using four-dimensional computed tomography: implications for radiotherapy planning
    Peter G Maxim
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 69:1395-401. 2007
    ....
  42. doi request reprint Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation
    Michael S Binkley
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 94:808-15. 2016
    ..We determined cumulative dose to critical structures, rates of toxicity, and outcomes following thoracic reirradiation...
  43. doi request reprint Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors
    Jeremy P Harris
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
    Clin Lung Cancer 16:475-85. 2015
    ..We also report an exploratory analysis of the prognostic value of the pre- and mid-RT positron emission tomography-computed tomography...
  44. doi request reprint Noninvasive pulmonary nodule elastometry by CT and deformable image registration
    Mohammadreza Negahdar
    Department of Radiation Oncology, Stanford University, United States
    Radiother Oncol 115:35-40. 2015
    ..To develop a noninvasive method for determining malignant pulmonary nodule (MPN) elasticity, and compare it against expert dual-observer manual contouring...
  45. pmc Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer
    J Martin Brown
    Department of Radiation Oncology, Stanford University School of Medicine, California 94305, USA
    Int J Radiat Oncol Biol Phys 78:323-7. 2010
    ....
  46. pmc An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer
    Viswam S Nair
    Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, USA
    PLoS ONE 8:e67733. 2013
    ....
  47. doi request reprint An automated method for comparing motion artifacts in cine four-dimensional computed tomography images
    Guoqiang Cui
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
    J Appl Clin Med Phys 13:3838. 2012
    ....
  48. doi request reprint Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?
    Millie Das
    Department of Radiation Oncology, Stanford University and Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305 5847, USA
    Curr Treat Options Oncol 11:24-35. 2010
    ....
  49. doi request reprint Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest
    David Benjamin Shultz
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Pract Radiat Oncol 4:272-8. 2014
    ..To identify clinical and dosimetric factors associated with vagus nerve (VN) and recurrent laryngeal nerve (RecLN) injury following stereotactic ablative radiation therapy (SABR) in the chest...
  50. doi request reprint Evaluation of a metal artifact reduction technique in tonsillar cancer delineation
    Jonathan A Abelson
    Department of Radiation Oncology, Stanford University, Stanford, California
    Pract Radiat Oncol 2:27-34. 2012
    ..We investigated a Digital Imaging and Communications in Medicine-based metal artifact reduction technique in tonsillar cancer delineation...
  51. doi request reprint Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema
    Michael S Binkley
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Int J Radiat Oncol Biol Phys 90:216-23. 2014
    ..We analyzed the dose-volume relationship for lobar volume reduction after stereotactic ablative radiation therapy (SABR) of lung tumors, hypothesizing that SABR could achieve therapeutic volume reduction if applied in emphysema...
  52. doi request reprint The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy
    David B Shultz
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California
    Pract Radiat Oncol 4:192-7. 2014
    ..We compared plan quality for AD vs AU when using volumetric modulated arc therapy (VMAT), and evaluated the sensitivity of AD plans to arm positioning variability...
  53. doi request reprint Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy
    Jayaji M Moré
    Department of Radiation Oncology Center for Atmospheric and Environmental Chemistry, Aerodyne Research Inc, Billerica, MA School of Nursing, University of Pennsylvania, Philadelphia, PA Kos Partners, Burlingame, CA Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
    J Thorac Oncol 9:957-64. 2014
    ....
  54. doi request reprint Investigation of four-dimensional computed tomography-based pulmonary ventilation imaging in patients with emphysematous lung regions
    Tokihiro Yamamoto
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, Stanford, CA 94305 5847, USA
    Phys Med Biol 56:2279-98. 2011
    ..A further study is needed to confirm these results...
  55. doi request reprint Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer
    Yelena Krupitskaya
    Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA
    Curr Treat Options Oncol 9:343-56. 2008
    ..A total dose of 50-54 Gy in 1.8-2 Gy fractions is appropriate...
  56. ncbi request reprint Impact of integrated PET/CT on variability of target volume delineation in rectal cancer
    Deep A Patel
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wibur Drive, Stanford, CA 94305 5847, USA
    Technol Cancer Res Treat 6:31-6. 2007
    ..The use of FDG and FLT did not appear to be different from this perspective...
  57. doi request reprint Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy
    Martin T King
    Department of Radiation Oncology, Stanford University, Stanford, California Electronic address
    Int J Radiat Oncol Biol Phys 92:683-90. 2015
    ..To determine whether regional ventilation, as measured using 4-dimensional computed tomography (4D-CT), declines after radiation therapy (RT)...
  58. pmc An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
    Aaron M Newman
    1 Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California, USA 2 Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California, USA 3
    Nat Med 20:548-54. 2014
    ..Finally, we evaluated biopsy-free tumor screening and genotyping with CAPP-Seq. We envision that CAPP-Seq could be routinely applied clinically to detect and monitor diverse malignancies, thus facilitating personalized cancer therapy. ..
  59. ncbi request reprint RT_Image: an open-source tool for investigating PET in radiation oncology
    Edward E Graves
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Technol Cancer Res Treat 6:111-21. 2007
    ..The development of tools such as this is critical in order to realize the potential of molecular imaging-guided radiation therapy...
  60. ncbi request reprint Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors
    Quynh Thu Le
    Department of Radiation Oncology, Stanford University, Stanford, California, USA
    J Thorac Oncol 1:802-9. 2006
    ..The purpose of this study was to report initial results of a phase I study using single-fraction stereotactic radiotherapy (RT) in patients with inoperable lung tumors...
  61. ncbi request reprint Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes
    Mersiha Hadziahmetovic
    Department of Radiation Oncology, Arthur G James Cancer Hospital, Ohio State University, Columbus, OH 43210, USA
    Discov Med 9:411-7. 2010
    ..This article provides updates of these aspects of SBRT for stage I NSCLC...
  62. doi request reprint Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy
    Nishita Kothary
    Division of Interventional Radiology, Stanford University Medical Center, 300 Pasteur Dr, H3652, Stanford, CA 94305 5642, USA
    J Vasc Interv Radiol 20:235-9. 2009
    ..To evaluate the safety and technical success rate of percutaneous fiducial marker implantation in preparation for image-guided radiation therapy...
  63. doi request reprint Complications of ablative therapies in lung cancer
    Sukhmani Padda
    Department of Medicine, Stanford University, Stanford, CA, USA
    Clin Lung Cancer 9:122-6. 2008
    ..These cases highlight the caution that should still be observed when recommending lung ablation strategies and the importance of selecting appropriate patients...
  64. ncbi request reprint The optimal use of radiotherapy in small cell lung cancer
    David B Shultz
    From the aDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California bDepartment of Radiation Oncology, Wexner Medical Center at The Ohio State University, James Cancer Hospital, Columbus, Ohio cDepartment of Radiation Oncology, University of Michigan Health System, Ann Arbor, Michigan dStanford Cancer Institute, Stanford, California and eInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California
    J Natl Compr Canc Netw 11:107-14. 2013
    ..Finally, prophylactic cranial irradiation improves survival in both limited- and extensive-stage disease that has responded to initial therapy...
  65. ncbi request reprint CyberKnife stereotactic ablative radiotherapy for lung tumors
    Iris C Gibbs
    Department of Radiation Oncology Stanford University and Cancer Center 875 Blake Wilbur Drive, MC 5847 Stanford, CA 94305 5847, USA
    Technol Cancer Res Treat 9:589-96. 2010
    ..We review the qualities of the CyberKnife platform for lung tumor SABR, and provide a summary of clinical data using this system specifically...
  66. pmc Retrospective analysis of artifacts in four-dimensional CT images of 50 abdominal and thoracic radiotherapy patients
    Tokihiro Yamamoto
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 72:1250-8. 2008
    ..To quantify the type, frequency, and magnitude of artifacts in four-dimensional (4D) CT images acquired using a multislice cine method...
  67. doi request reprint Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans
    Magdalena Bazalova-Carter
    Department of Radiation Oncology, Stanford University, Stanford, California 94305
    Med Phys 42:2615-25. 2015
    ..Additionally, VHEE plans were compared to clinical state-of-the-art volumetric modulated arc therapy (VMAT) photon plans for three cases...
  68. pmc Optimization of an on-board imaging system for extremely rapid radiation therapy
    Erica M Cherry Kemmerling
    Department of Radiology, Stanford University, Stanford, California 94305
    Med Phys 42:6757-67. 2015
    ..In this study, three different detectors for a custom on-board CT system were investigated to select the best design for integration with an extremely rapid radiation therapy system...
  69. doi request reprint Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer
    David Benjamin Shultz
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA Department of Oncology, University of Torino, Italy and Département de Radiothérapie, Centre Hospitalier Lyon Sud, Pierre Benite, France
    J Thorac Oncol 9:1426-33. 2014
    ..We review the role and clinical experience of stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. ..
  70. ncbi request reprint Metabolic tumor burden predicts for disease progression and death in lung cancer
    Percy Lee
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 69:328-33. 2007
    ..However, stage may be simply a surrogate for underlying tumor burden. Our purpose was to assess the prognostic value of tumor burden measured by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging...
  71. doi request reprint Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma
    Wendy Hara
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 71:393-400. 2008
    ..To determine long-term outcomes in patients receiving stereotactic radiotherapy (SRT) as a boost after external beam radiotherapy (EBRT) for locally advanced nasopharyngeal carcinoma (NPC)...
  72. ncbi request reprint Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma
    Andrew Quon
    Division of Nuclear Medicine, Department of Radiology, Stanford University Medical Center, Stanford, California 94305, USA
    J Nucl Med 48:58S-67S. 2007
    ....